Press release
Protection of pharmaceutical innovation in Europe - Data exclusivity & Roche Bolar
Especially topics as the new data exclusivity scheme and the implementation of Roche Bolar will be addressed by:
Ian Dodds-Smith, Arnold & Porter LLP, London;
Dr. John Lisman, Medicines Evaluation Board, Den Haag;
Dorthe Poulsen, The Danish Medicines Agency, København;
Burkhard Sträter, law firm Sträter, Bonn
For further information please check
http://www.forum-institut.de/sites/veranstaltung.asp?SemNr=0605238
or contact
Dr. Henriette Wolf-Klein
Deputy head Pharma
FORUM Institute of Management, Heidelberg
Vangerowstraße 18
69115 Heidelberg
Tel. 0049 6221 500 680
Fax. 00 49 6221 500 618
h.wolf-klein@forum-institut.de
FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CPMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Protection of pharmaceutical innovation in Europe - Data exclusivity & Roche Bolar here
News-ID: 4238 • Views: …
More Releases from FORUM Institute of Management
Step by step through Medical Device Law
Which laws apply to a clinical trial by medical devices? Which forms of advertising are permitted? Under which circumstances is the manufacturer liable? And when is the user? The current 4th amendment of the German Medical Device Act (MPG) and the associated new requirements for manufacturers. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of discussions.
FORUM Institute fuer Management,…
Quality Documentation of Medicinal Substances incorporated in Medical Devices
In order to demonstrate appropriate quality for incorporated medicinal substances in medical devices (ancillary medicinal substances), applicants need to provide information and scientific data, which are similar to that requested by authorithies for API"s in medicinal products. These data are submitted to the competent authorities by the notified body involved. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of…
The safety inspector for medical device
Every medical device company had to reappoint somebody to the safety inspector of medical devices. This positon comprised a great accountability with personal liability in the field of the company and also to the user. The safety inspector for medical device is bound to procedural requirements. The postion proceed an important role in the risk management. Das FORUM Institut für Management extend to this tender subject an…
Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT
For the first time, all "advanced therapies" (gene therapy, somatic cell therapy and tissue engineering products) will be centralised in a single procedure of the newly adopted European Regulation No 1394/2007 ("the Regulation") on advanced therapy medicinal products (ATMPs). This regulation lays down specific
rules concerning the authorisation, supervision and pharmacovigilance of ATMPs and will apply as of 30 December 2008.
The focus of this seminar will be on the required legitimate…
More Releases for Medicines
Global Veterinary Medicines And Vaccines Market Size by Application, Type, and G …
According to Market Research Intellect, the global Veterinary Medicines And Vaccines market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The veterinary medicines and vaccines market is expanding steadily due to rising pet ownership, livestock farming,…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Regenerative Medicines: Bone and Joint Applications
Summary:
The global market for regenerative medicine for bone and joint applications was valued at REDACTED in 2021. By technology, this market is segmented into biomaterials, stem cell therapy and tissue engineering. The tissue engineering segment recorded REDACTED revenue in 2021 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED during the forecast period. The rapid growth rate of the tissue engineering segment is attributed to…
Herbal Medicinal Products Market Report 2018: Segmentation by Type (Ayurvedic Me …
Global Herbal Medicinal Products market research report provides company profile for Arkopharma SA, Nutraceutical Corporation, Blackmore Limited, Potters Herbal Medicine, NBTY Inc, Bio-Botanica Inc, Himalaya Drug Company, Twinlab Corporation, Arizona Natural Products and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
Market Access for Oncology Medicines to Witness Incredibly Challenging Owing to …
Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more stringent scientific and value assessments and economic pressures on national budgets and health systems. Although, 5EU markets have implemented patient access schemed to ensure early access to innovative oncology medicines with high unmet need, the increasing requirements for improved clinical benefits and better cost-effectiveness of medicines has resulted in more stringent…
Animal Pharm - Medicines for Aquaculture 2016
ReportsWorldwide has announced the addition of a new report title Animal Pharm - Medicines for Aquaculture 2016 to its growing collection of premium market research reports.
The fast-growing aquaculture health industry is of increasing interest to the mainstream animal health sector. This is demonstrated by the entry and expansion of the big global players into this market i.e. MSD, Elanco and Zoetis among others. It is estimated to be worth around…
